Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel

Canadian Journal of Cardiology

Volumn 19, Issue 3, 2003, Pages 300-302

  Nguyen Ho, Phong ^a   Kleiman, Neal S ^a   Verani, Mario S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Myocardial infarction; Vasopasm

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CARBOPLATIN; CISPLATIN; GEMCITABINE; GLYCERYL TRINITRATE; HEPARIN; LONG ACTING DRUG; NAVELBINE; NITRATE; PACLITAXEL; ANTINEOPLASTIC AGENT;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATRIOVENTRICULAR BLOCK; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CORONARY ARTERY SPASM; DEFIBRILLATION; DIAPHORESIS; DOSE RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FLUSHING; HEART ARREST; HEART VENTRICLE TACHYCARDIA; HUMAN; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; SIDE EFFECT; SWEAT GLAND DISEASE; SYNCOPE; THORAX PAIN; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE CONDUCTION SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; PATHOPHYSIOLOGY;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ARREST; HEART CONDUCTION SYSTEM; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MYOCARDIAL INFARCTION; PACLITAXEL;

EID: 0037444997     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Rowinsky EK, McGuire WP, Guarnieri T, Fisherman JS, Christian MC, Donehower RC. Cardiac disturbances during the administration of Taxol. J Clin Oncol 1991;9:1704-12.
2. Arbuck SG, Strauss H, Rowinsky E, et al. A reassessment of the cardiac toxicity associated with Taxol. Monogr Natl Cancer Inst 1993;15:117-30.
3. The TIMI investigators. Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-56.
4. Waller BF. Nonatherosclerotic coronary heart disease. In: Alexander RW, Schlant RC, Fuster V, et al, eds. Hurst's The Heart, 9th edn. New York: McGraw-Hill, 1998:1197-240.
5. Hekmat E. Fatal myocardial infarction potentially induced by paclitaxel. Ann Pharmacother 1996;30:1110-2.
6. Laher S, Karp SJ. Acute myocardial infarction following paclitaxel administration for ovarian carcinoma. Clin Oncol (R Coll Radiol) 1997;9:124-6.
7. Bristow MR, Ginsburg R, Harrison DC. Histamine and the human heart: The other receptor system. Am J Cardiol 1982;49:249-51.
8. Lodge NJ. Direct vasoconstrictor effects of sandimmune (cyclosporine A) are mediated by its vehicle cremophor EL: Inhibition by the thromboxane A2/prostaglandin endoperoxide receptor antagonist ifetroban. J Pharmacol Exp Ther 1994;271:730-4.
9. Yaris E, Tuncar M, Kayaalp SO, Ilhan M. Direct vascular smooth muscle contractile effect of cyclosporine A and its vehicle in rabbit isolated arteries. Arch Int Pharmacodyn Ther 1994;327:166-74.
10. Alloatti G, Penna C, Gallo MP, Levi RC, Bombardelli E, Appendino G. Differential effects of paclitaxel and detrivatives on guinea pig isolated heart and papillary muscle. J Pharmacol Exp Ther 1998;284:561-7.